ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Aubrey C. Galloway
Richard J. Shemin
Donald D. Glower
Thomas A. Burdon
Bruce A. Reitz
Stephen B. Colvin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galloway, A. C.
Right arrow Articles by Colvin, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galloway, A. C.
Right arrow Articles by Colvin, S. B.

Ann Thorac Surg 1999;67:51-58
© 1999 The Society of Thoracic Surgeons


Original Articles

First report of the port access international registry

Aubrey C. Galloway, MDa, Richard J. Shemin, MDb, Donald D. Glower, MDc, Joseph H. Boyer, Jr, MDd, Mark A. Groh, MDe, Richard E. Kuntz, MDf, Thomas A. Burdon, MDg, Greg H. Ribakove, MDa, Bruce A. Reitz, MDg, Stephen B. Colvin, MDa

a New York University Medical Center, New York, New York, USA
b Boston University Medical Center, Boston, Massachusetts, USA
c Duke University Medical Center, Durham, North Carolina, USA
d Florida Hospital, Orlando, Florida, USA
e Memorial Mission Hospital, Asheville, North Carolina, USA
f Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
g Stanford University Medical Center, Stanford, California, USA

Address reprint requests to Dr Galloway, New York University Medical Center, 530 First Ave, Suite 9V, New York, NY 10016

Presented at the Poster Session of the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 26–28, 1998.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
Background. For minimally invasive cardiac operations to be widely applicable, the risks must be equivalent to those of standard open-chest operations. This study analyzed the outcomes of patients recorded in the multicenter Port Access (PA) International Registry to establish operative risks.

Methods. Data were analyzed for intent to treat in 583 patients who underwent PA coronary artery bypass grafting (CABG), 184 who underwent PA mitral valve replacement, and 137 who underwent PA mitral valve repair at 121 centers.

Results. Port Access was attempted in 1,063 patients and completed in 1,004 (94%). The operative mortality rate was 1% for PA CABG, 3.3% for PA mitral valve replacement, and 1.5% for PA mitral valve repair. Perioperative morbidity was low in all categories: stroke = 1.1% to 3.6%, myocardial infarction = 0 to 1%, primary procedure reoperation = 0 to 0.7%, renal failure = 0.2% to 0.7%, multiorgan failure = 0 to 0.5%, and atrial fibrillation = 5% to 7.3%.

Conclusions. Data on 1,063 patients from 121 centers demonstrate that PA CABG and PA mitral valve operations can be performed safely, with morbidity and mortality rates similar to those associated with open-chest operations. Further studies are indicated to establish the long-term efficacy of this method and to analyze its effect on recovery time.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
The potential advantages of minimally invasive cardiac operations, such as diminished pain and trauma, improved cosmetic results, and shorter recovery times, have compelled many centers to explore newly available technologies that facilitate precise and effective minimally invasive techniques. For these approaches to be accepted, however, they must meet the challenge of being less invasive while still achieving safety and efficacy outcomes equivalent to those of established techniques. For most cardiac procedures, this will continue to require the use of cardiopulmonary bypass and cardioplegic arrest.

A major breakthrough in the ability to widen the application of minimally invasive cardiac operations was the development of a system for cardiopulmonary bypass and cardioplegic arrest that did not require a sternotomy incision. This new approach was based on the use of an intraaortic balloon catheter for aortic occlusion and cardioplegia delivery, as proposed independently by Peters [1] and by Stevens and colleagues [2]. The concept was developed technologically by industry (Heartport, Inc., Redwood City, CA) and termed the Port Access System. With this system, cardioplegia is delivered either through the proximal port of the balloon catheter or through a percutaneously placed coronary sinus catheter. A separate set of instruments is designed to provide intracardiac retraction and to allow the surgeon to work through small incisions, or "ports." Thus, the surgeon potentially can achieve standard myocardial protection and perform precise cardiac operations without a sternotomy.

The Port Access approach initially was tested by the research laboratories of Stanford University and New York University [27]. These studies experimentally established the safety and efficacy of the myocardial protection system, the feasibility and reproducibility of single-vessel and multivessel coronary artery bypass grafting (CABG), and the applicability of the approach for mitral valve operations. A preliminary clinical trial was reported by Pompili and associates in 1996 [8].

Subsequently, U. S. Food and Drug Administration phase 1 clinical trials were performed at Stanford University for CABG [9], and at Stanford University and the New York University Medical Center for mitral valve operations. After clearance was obtained from the Food and Drug Administration in October 1996, several institutionally based prospective trials were initiated, with excellent early results in terms of safety and efficacy [1012]. The early Port Access technique for CABG was well described by Ribakove and coworkers [13], and the mitral valve technique was described by Fann and colleagues [14] and by Galloway and associates [11].

To gather scientific information and data from a large number of centers, the Port Access International Registry (PAIR) was established for centers that used the Port Access approach. Data for the PAIR were submitted from participating centers (Appendix 1) for analysis of demographics and morbidity and mortality outcomes. To avoid potential conflicts of interest and maintain intellectual independence, the data were overseen by a scientific steering committee comprised of cardiac physicians and administered by an independent clinical research organization.

The current study, which is the first from the PAIR, was designed to analyze morbidity and mortality outcomes from the 121 centers that were participating in 1997. The study was designed to define the incidence of complications when the Port Access approach was used for CABG or mitral valve operations to establish the safety of the Port Access technique. Data collection began on April 1, 1997, to allow for start-up completion by multiple centers, and was continued through January 1, 1998.


    Material and methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
A total of 1,063 cases from 121 centers were reported to the PAIR between April 1, 1997, and January 1, 1998. This included 904 isolated CABG (n = 583) or mitral valve (n = 321) procedures that are the topic of this analysis. The data represent a relatively early experience with Port Access operations, with only two centers reporting more than 75 cases, 16 centers reporting 25 to 75 cases, and 103 centers reporting fewer than 25 cases.

Outcome data were compiled from registry reports and from the PAIR clinical report forms. Data were collected on patient demographics and perioperative mortality and major morbidity worldwide, and on median postoperative length of stay for patients in the United States. Morbidity analysis included all strokes, Q-wave myocardial infarctions, new-onset atrial fibrillation requiring therapy, primary reoperation for revascularization or valvular dysfunction, and reoperation for other thoracic complications, such as bleeding, pericardial effusion, or tamponade. Renal failure was defined as an elevated creatinine level of greater than 3.0 for 5 days, or as the need for dialysis. The clinical diagnosis of multiorgan failure required serious ongoing compromise of two or more major organ systems. Operative mortality included in-hospital and 30-day events. Both morbidity and mortality data were analyzed for intention to treat using Port Access and were reported as incidence.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
Of the 1,063 procedures in which the surgeon intended to use Port Access, 1,004 (94.4%) were completed successfully, which was defined as successful use of the endoclamp without conversion to sternotomy. Conversions, when necessary, occurred for various reasons, including failure to pass the guidewire or endoclamp, poor exposure, and aortic dissection. Overall, the incidence of major complications leading to abandonment of the Port Access approach and conversion to sternotomy was low. The most worrisome complication, aortic dissection, had an overall incidence of 0.75% (8 of 1,063 patients), but this decreased from an initial incidence of 1.3% (7 of 531 patients) in the first half of the series to an incidence of 0.18% (1 of 532 patients) in the second half of the series.

Coronary artery bypass grafting comprised 55% of Port Access procedures, whereas mitral valve repair or replacement comprised 30%. The remaining 15% of cases were comprised of other procedures, such as multivalve operations, valve operations plus CABG, or atrial septal defect repair (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Distribution of Procedures (Cases Completed Using Port Access)

 
Port access coronary artery bypass grafting
During the reporting period, 583 intended Port Access CABG procedures were reported to the registry, 555 (95%) of which were completed using Port Access. Forty-eight percent (n = 265) were single-vessel CABG, 31% (n = 173) were double-vessel CABG, and 21% (n = 117) were triple-vessel CABG or more (Table 1).

The patients who underwent these procedures ranged in age from 26 to 86 years (mean, 60.5 years) and in weight from 41 to 158 kg (mean, 83.1 kg). Seventy-six percent were male and 34% were female (Table 2). Elective operations accounted for 87.2% of cases; 12.8% were urgent or emergency procedures. First operations accounted for 95.5% and reoperations for 4.5%.


View this table:
[in this window]
[in a new window]
 
Table 2. Characteristics of Patients Who Underwent Coronary Artery Bypass Grafting

 
Port access coronary artery bypass grafting morbidity and mortality
Major perioperative morbidity and mortality outcomes for the 583 cases of CABG that were reported to the PAIR were analyzed and are reported in Table 3. The operative mortality rate for Port Access CABG was 1%. Perioperative complications included stroke in 2.2% of cases, myocardial infarction in 1%, new-onset atrial fibrillation in 5%, reoperation for primary procedure in 0, reoperation for other causes in 1.5%, renal failure in 0.2%, and multiorgan failure in 0.


View this table:
[in this window]
[in a new window]
 
Table 3. Morbidity and Mortality of Patients Who Underwent Coronary Artery Bypass Grafting (n = 583)

 
Port access mitral valve operations
A total of 321 mitral valve procedures were reported to the PAIR during the study period; 184 were valve replacements and 137 were valve repairs. Two hundred ninety-nine procedures (93.2%) were completed using Port Access, whereas 22 (6.8%) had to be converted to sternotomy.

Demographic data for the patients who underwent mitral valve operations are shown in Table 4. The patients ranged in age from 26 to 82 years (mean, 57.5 years) and in weight from 43 to 132 kg (mean, 72.8 kg). Males comprised 47.7% of the patient cohort and females comprised 53.3%. Elective operations accounted for 98% of cases and nonelective operations accounted for 2%. First operations constituted 90.9% of the procedures and reoperations constituted 9.1%.


View this table:
[in this window]
[in a new window]
 
Table 4. Characteristics of Patients Who Underwent Mitral Valve Operations

 
Port access mitral valve replacement morbidity and mortality
Major perioperative morbidity and mortality replacement are shown in Table 5. The operative mortality rate was 3.3% for 184 Port Access mitral valve replacement procedures. Perioperative complications included stroke in 1.1% of patients, myocardial infarction in 0, new-onset atrial fibrillation in 7.1%, primary procedure reoperation in 0, reoperation for other causes in 3.8%, renal failure in 0.5%, and multiorgan failure in 0.5%.


View this table:
[in this window]
[in a new window]
 
Table 5. Operative Morbidity and Mortality of Patients Who Underwent Mitral Valve Operations (n = 321)

 
Port access mitral valve repair morbidity and mortality
Major morbidity and mortality outcomes for the patients who underwent mitral valve repair are shown in Table 5. The operative mortality rate for Port Access mitral valve repair was 1.5% in 137 patients. Perioperative complications included stroke in 3.6% of patients, myocardial infarction in 0, new-onset atrial fibrillation in 7.3%, reoperation for primary procedure in 0.7%, reoperation for other causes in 1.5%, renal failure in 0.7%, and multiorgan failure in 0.

Postoperative length of stay
Length of stay was recorded for 360 of the patients who underwent CABG procedures and 156 of the patients who underwent mitral valve procedures, all of whom were treated in the United States. The median length of stay was 4 days for Port Access CABG procedures, regardless of the number of vessels grafted. The median length of stay was 6 days for Port Access mitral valve replacement and 5 days for Port Access mitral valve repair.


    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
Minimally invasive cardiac operations represent a significant change in the way cardiac surgeons treat certain patients. Their underlying premise is that a smaller incision will cause less postoperative pain, resulting in a quicker overall recovery. If minimally invasive cardiac operations are to be widely applicable, they must be proved as safe and efficacious as standard procedures performed through a median sternotomy.

The Port Access approach with peripheral cardiopulmonary bypass, endovascular aortic occlusion, and cardioplegia arrest allows the surgeon to use standard anastomotic techniques on a still, protected heart, and to perform open heart valvular operations. If patients are selected appropriately for Port Access CABG, this approach should be able to produce patency results similar to those of open-chest methods because the distal anastomotic technique is not significantly different from the one used in standard open-chest procedures. Clinical data reported by Ribakove and associates [10] were encouraging in this regard, demonstrating no deaths and an overall bypass graft anastomotic patency rate of 96%, with 100% patency of left internal mammary-to-left anterior descending grafts, on routine angiographic follow-up in 32 patients.

The data in the current report are similarly encouraging. The 1% incidence of myocardial infarction in the 583 patients who underwent Port Access CABG and the minimal need for primary procedure reoperations are clinical evidence that the technique is reproducible in terms of anastomotic accuracy for coronary revascularization. Because all zones of the heart can be reached for grafting with this arrested-heart approach, Port Access CABG has been used increasingly in a substantial number of patients with multivessel disease. Multivessel CABG procedures accounted for 52% of the Port Access CABG procedures overall in this report, and for 56% of those in the second half of the study period. The technique eventually evolved so that most vein grafts now are brought off the ascending aorta for multivessel CABG, similar to open-chest methods.

An even better experience seems to be evolving with Port Access mitral valve operations, with extremely encouraging institutional reports. The small thoracotomy incision and internal cardiac retraction system provide excellent visualization of the mitral valve in the arrested heart. In some cases, the exposure appears to be better than that obtained with a standard sternotomy incision. The valve repair or replacement procedure is performed similarly to the standard open-chest method, except that the surgeon uses specifically designed long instruments and "knot pushers" to facilitate the technical process. Videoscopic assistance generally has not been necessary for visualization.

The initial New York University series [11] evaluated 131 mitral valve procedures performed using the Port Access technique and demonstrated that valve repair or replacement could be achieved routinely with an efficacy equivalent to that of open-chest methods. The operative mortality rate was 1.1% for isolated Port Access valve operations in that report. Glower and associates [12] reported similar findings, and presented data suggesting that early recovery and quality of life were better with the Port Access approach than with standard open-chest techniques. These encouraging findings need further validation.

In the current report on PAIR data, the morbidity and mortality outcomes of the 583 patients who underwent CABG and the 321 patients who underwent mitral valve procedures demonstrate that the Port Access technique is not associated with any significantly increased risk in appropriately selected patients. Overall, the data reported here suggest that the risks associated with the Port Access technique for both CABG and mitral valve operations are sufficiently low to warrant wider application of this technique, and that the perioperative risks are comparable to those associated with standard open-chest procedures. Speed of recovery, perioperative pain, and quality of life were not addressed in this study.

Two specific potential complications, which were troubling when the Port Access approach first was introduced, deserve particular attention. The first concerns the risk of aortic dissection. Reintroducing the routine use of retrograde perfusion through the femoral artery for extracorporeal perfusion is controversial because the incidence of aortic dissection was high when femoral perfusion was used routinely in the past. We found an overall incidence of aortic dissection of 0.75% (8 of 1,063 patients) in the Port Access study patients. It is of interest that the incidence of aortic dissection decreased as the registry progressed and the risk of aortic dissection was actively addressed.

Factors that minimized the risk of dissection included the progressive development of improved catheters with more flexible guidewires, strict adherence to the Seldinger technique for catheter placement, avoidance of catheter placement and conversion to an open-chest technique when the guidewire would not pass, and selected use of vascular screening techniques when severe peripheral vascular disease was suspected on the basis of the history and physical examination. The introduction of these technical modifications and operative guidelines appears to have had a positive effect because the incidence of aortic dissection dropped from 1.3% in the first half of the study period to 0.18% in the last 532 patients. The risk at this point is comparable to the risk of aortic dissection associated with ascending aortic cannulation and antegrade perfusion.

The second potential concern with the Port Access approach is whether the removal of air will be adequate. Because the chest is not open with the Port Access technique and the surgeon does not have access to the apex of the heart for air removal, techniques had to be designed to ensure adequate removal of air from the heart. Several general techniques were developed for this purpose, one of which is described here.

When the mitral valve procedure is completed, a vent is passed across the valve into the left ventricle and blood return is increased to the heart to displace air through the untied atriotomy suture line while gently inflating the lungs. The proximal port of the endoclamp catheter is placed on gentle suction as the endoclamp is deflated and the heart is reperfused while fibrillating. With the heart fibrillating, both the transvalvular vent and the aortic endoclamp catheter are placed on gentle suction while the lungs are inflated and the heart and chest wall are massaged gently to aid in the removal of air. Transesophageal echocardiography is used to monitor air removal. The endoclamp then is partially reinflated while suction on the aortic root and transvalvular vents is continued and the heart is defibrillated. Finally, after air appears to have been removed adequately on echocardiographic surveillance, the endoclamp again is deflated and the vents are removed. Although this particular technique was not used uniformly by every center, similar strategies for removing air were used by most centers.

Overall, air removal appears to have been successful because the risk of stroke in the patients who underwent Port Access mitral valve procedures in this report was less than 3%, which is not significantly different from the risk associated with open-chest mitral valve procedures. We conclude that, when attention is paid to the use of proper technique, the Port Access approach does not introduce an increased risk of air embolization or stroke.

A somewhat unexpected but relevant finding in this study was the remarkably low incidence of new-onset postoperative atrial fibrillation in the PAIR study population. The incidence was low in both the CABG and the mitral valve populations, and it was dramatically lower than that reported in other large data bases for patients undergoing conventional operations. Proposed mechanisms for this decreased propensity toward atrial fibrillation include the absence of a right atriotomy incision and suture line with the Port Access technique, and the fact that the atrium is manipulated less and is not exposed to light and heat, resulting in less postoperative inflammation. Whatever the mechanism, if this observation is validated in future studies, a decreased incidence of postoperative atrial fibrillation eventually would have an effect on patient morbidity and postoperative length of stay.

In conclusion, the ultimate goal is for minimally invasive cardiac operations to be as safe and effective as standard operations but with less trauma and pain. If this proves to be a valid and achievable goal, the overall morbidity associated with cardiac operations could be decreased progressively, with great benefit to patients. The experience reported here from the PAIR data base suggests that the minimally invasive Port Access approach can be used safely, with overall risks similar to those associated with open-chest methods. The incidence of postoperative atrial fibrillation was especially low, possibly because a right atrial incision was not required.

As minimally invasive cardiac operations are used more widely, both the technologic equipment and the operative techniques should continue to evolve, ultimately resulting in a safer procedure and an improved patient outcome. It is essential that the data be evaluated carefully to determine the scientific validity of these new approaches. The goal of all fields of medicine, and of cardiac surgery in particular, should be to provide improved treatment outcomes with less morbidity. Further studies are indicated to establish the long-term efficacy of Port Access operations and to analyze the effect of these procedures on postoperative recovery and quality of life.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 
Drs. Burdon, Groh, and Shemin acted as consultants to Heartport. Dr. Reitz is a member of the Scientific Advisory Board for Heartport and received financial compensation in the form of honoraria, as did Drs. Boyer and Glower. Dr. Ribakove has stock holding in Heartport. Financial contributions made by Heartport were for the Port-Access Surgery Registry, Port-Access International Registry brief case report form, and Comprehensive case report form. NYU Medical Center received partial support for a clinical data coordinator.


    Appendix 1
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 

PARTICIPATING CENTER


CITY


STATE


Allegheny General Hospital Pittsburgh PA
Baptist Medical Center Oklahoma City OK
Baptist Medical Center Little Rock AR
Baptist Medical Center Montclair Birmingham AL
Baptist Memorial Hospital Memphis TN
Barnes-Jewish Hospital St. Louis MO
Boston Medical Center Boston MA
Brigham and Women’s Hospital Boston MA
Bryn Mawr Hospital Bryn Mawr PA
Cedars-Sinai Medical Center Los Angeles CA
Central Baptist Hospital Lexington KY
Chippenham Medical Center Richmond VA
Cleveland Clinic Foundation Cleveland OH
Deborah Heart and Lung Center Browns Mills NJ
Doctors Medical Center Modesto CA
Duke University Hospital Durham NC
Encino-Tarzana Regional Medical Center Encino CA
Florida Hospital Medical Center Orlando FL
Fresno community Hospital and Medical Center Fresno CA
Georgetown University Hospital Washington DC
Grant-Riverside Methodist Hospitals Columbus OH
Henrico Doctors’ Hospital Richmond VA
Hermann Hospital Houston TX
Inova Fairfax Hospital Falls Church VA
Johns Hopkins Hospital Baltimore MD
Latter Day Saints Hospital Salt Lake City UT
Lehigh Valley Hospital Allentown PA
Little Company of Mary Hospital Torrance CA
Los Robles Regional Medical Center Thousand Oaks CA
Loyola University Medical Center Maywood IL
Massachusetts General Hospital Boston MA
Medical Center Hospital Odessa TX
Medical College of Ohio Hospital Toledo OH
Mission St. Joseph’s Health System Asheville NC
New Mexico Heart Institute Albuquerque NM
New York University Medical Center New York NY
Ochsner Foundation Hospital New Orleans LA
Palo Alto Veterans Affairs Medical Center Palo Alto CA
Presbyterian Hospital of Dallas Dallas TX
Redding Medical Center Redding CA
Research Medical Center Kansas City MO
Rochester General Hospital Rochester NY
Rush-Presbyterian-St. Luke’s Medical Center Chicago IL
Saint Francis Hospital Tulsa OK
Saint Joseph’s Hospital of Atlanta Atlanta GA
Schumpert Medical Center Shreveport LA
Southern Illinois University School of Medicine Springfield IL
Spectrum Health Grand Rapids MI
St. Francis Health Care System Hartford CT
St. Francis Hospital Roslyn NY
St. Francis Hospital Center and Health Centers Beech Grove IN
St. John Medical Center Tulsa OK
St. Joseph Medical Center Towson MD
St. Luke’s Medical Center Milwaukee WI
St. Mary’s Hospital Richmond VA
St. Thomas Hospital Nashville TN
Stanford University Hospital Stanford CA
The Sanger Clinic, PA and Carolinas Medical Center Charlotte Nc
Union Memorial Hospital Baltimore MD
University Community Hospital Tampa FL
University Hospital Augusta GA
University of Louisville School of Medicine Louisville KY
Department of Thoracic and Cardiothoracic Surgery and Jewish Hospital Heart/Lung Institute, University of Pennsylvania Philadelphia PA
University of Southern California Pasadena CA
University of Utah, School of Medicine Salt Lake City UT
University of Virginia Medical Center Charlottesville VA
Veterans Affairs Medical Center San Diego San Diego CA
Wake Medical Center Raleigh NC
Walter O. Boswell Memorial Hospital Sun City AZ
Westchester County Medical Center Valhalla NY
Willis Knighton Medical Center Shreveport LA
Akademiska Sjukhuset Uppsala Uppsala Sweden
Bergmannshell-Universitatsklinikum Bochum Germany
C.H.U. Lyon Louis Pradel Lyon France
C.H.U.R. Metz Hospital Bon Secours Metz France
Clinique Clairval Marseille France
Dresden University Dresden Germany
Freeman Hospital Newcastle Upon Tyne UK
Harley Stree Hospital, Columbia Health Group London UK
Her-kreislaufzentrum Leipzig Germany
Hopital Broussais Paris France
Hopital Europeen de Paris-La Roseraie Aubervilliers France
Hospital do Meixoeiro Vigo Spain
Hospital Doce de Octubre Madrid Spain
Hospital Santa Cruz Linda-a-Velha Portugal
Klinikum Grosshadern Munich Germany
Krankenhaus Links der Wesser Bremen Germany
Lille/Hospital Cardiologique Lille France
Onze Lieve Vrouw Clinic Aalst Belgium
Policlinico San Matteo Pavia Italy
Royal Infirmary of Edinburgh Edinburgh Scotland
University of Barcelona Barcelona Spain
University of Frankfurt Frankfurt a.M. Germany
Escorts Heart Institute and Research New Delhi India
National Heart Institute

Kuala Lampur

Malaysia


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Appendix 1
 References
 

  1. Peters W.S. Minimally invasive cardiac surgery by cardioscopy. Australian J Cardiac Thorac Surg 1993;2:152-154.
  2. Stevens J.H., Burdon T.A., Peters W.S., et al. Port-access coronary artery bypass grafting: a proposed surgical method. J Thorac Cardiovasc Surg 1996;111:567-573.[Abstract/Free Full Text]
  3. Stevens J.H., Burdon T.A., Siegel L.C., et al. Port-access coronary artery bypass with cardioplegic arrest: acute and chronic canine studies. Ann Thorac Surg 1996;62:435-441.[Abstract/Free Full Text]
  4. Pompili M.F., Stevens J.H., Burdon T.A., et al. Port-access mitral valve replacement in dogs. J Thorac Cardiovasc Surg 1996;112:1268-1274.[Abstract/Free Full Text]
  5. Schwartz D.S., Ribakove G.H., Grossi E.A., et al. Minimally invasive mitral valve replacement: port-access technique, feasibility and myocardial functional preservation. J Thorac Cardiovasc Surg 1997;113:1022-1031.[Abstract/Free Full Text]
  6. Schwartz D.S., Ribakove G.H., Grossi E.A., et al. Minimally invasive cardiopulmonary bypass with cardioplegic arrest: a closed chest technique with equivalent myocardial protection. J Thorac Cardiovasc Surg 1996;111:556-566.[Abstract/Free Full Text]
  7. Schwartz D.S., Ribakove G.H., Grossi E.A., et al. Single and multivessel port-access coronary artery bypass grafting with cardioplegic arrest: technique and reproducibility. J Thorac Cardiovasc Surg 1997;114:46-52.[Abstract/Free Full Text]
  8. Pompili M.F., Yakub A., Siegel L.C., Stevens J.H., Awang Y., Burdon T.A. Port-access mitral valve replacement: initial clinical experience. Circulation 1996;94(Suppl 1):533.
  9. Reitz B.A., Stevens J.H., Burdon T.A., et al. Port-access coronary artery bypass grafting: lessons learned in a phase 1 clinical trial. Circulation 1996;94(Suppl 1):52.[Abstract/Free Full Text]
  10. Ribakove G.H., Miller J.S., Anderson R.V., et al. Minimally invasive port-access coronary artery bypass grafting with early angiographic follow-up: initial clinical experience. J Thorac Cardiovasc Surg 1998;115:1101-1110.[Abstract/Free Full Text]
  11. Galloway A.C., Ribakove G.H., Grossi E.A., et al. Minimally invasive port-access valvular surgery: initial clinical experience. Circulation 1997(Suppl 1):508.
  12. Glower DD, Landolfo KP, Clements F, et al. Mitral valve operation via port-access versus median sternotomy. Eur J Cardiothorac Surg. In press.
  13. Ribakove G.H., Galloway A.C., Grossi E.A., et al. Port-access coronary artery bypass grafting. Semin Thorac Cardiovasc Surg 1997;9:312-319.[Medline]
  14. Fann J.I., Pompili M.F., Burdon T.A., Stevens J.H., St. Goar F.G., Reitz B.A. Invasive mitral valve surgery. Semin Thorac Cardiovasc Surg 1997;9:320-330.[Medline]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. C. Lee, B. Desai, and D. D. Glower
Results of 141 Consecutive Minimally Invasive Tricuspid Valve Operations: An 11-Year Experience
Ann. Thorac. Surg., December 1, 2009; 88(6): 1845 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Inan, A. Ucak, A. U. Gullu, and A. T. Yilmaz
Iliac Arterial Intussusception From an Aortic Endoclamp Catheter.
Ann. Thorac. Surg., July 1, 2009; 88(1): 262 - 263.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Modi, E. Rodriguez, W. C. Hargrove III, A. Hassan, W. Y. Szeto, and W. R. Chitwood Jr.
Minimally invasive video-assisted mitral valve surgery: A 12-year, 2-center experience in 1178 patients.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
M. Glauber, J. H. Karimov, P. A. Farneti, A. G. Cerillo, F. Santarelli, M. Ferrarini, P. Del Sarto, M. Murzi, and M. Solinas
Minimally invasive mitral valve surgery via right minithoracotomy
MMCTS, January 22, 2009; 2009(0122): 3350.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Modi, A. Hassan, and W. R. Chitwood Jr.
Minimally invasive mitral valve surgery: a systematic review and meta-analysis
Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 943 - 952.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. K. Rosengart, T. Feldman, M. A. Borger, T. A. Vassiliades Jr, A. M. Gillinov, K. J. Hoercher, A. Vahanian, R. O. Bonow, and W. O'Neill
Percutaneous and Minimally Invasive Valve Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation, April 1, 2008; 117(13): 1750 - 1767.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. W. Hammon
Extracorporeal Circulation: Perfusion System
Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370.
[Full Text]


Home page
ICVTSHome page
E. Sagbas, B. Caynak, C. Duran, O. Sen, B. Kabakci, I. Sanisoglu, and B. Akpinar
Mid-term results of peripheric cannulation after port-access surgery
Interactive CardioVascular and Thoracic Surgery, December 1, 2007; 6(6): 744 - 747.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
Y. K Mishra, H. Wasir, K. K Sharma, Y. Mehta, and N. Trehan
Totally Endoscopic Coronary Artery Bypass Surgery
Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 447 - 451.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
F. Farhat, M. Vergnat, P. Blanc, P. Chiari, and O. Jegaden
Which place for Port AccessTM surgery in coronary artery bypass grafting? A mid-term follow up study
Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 71 - 74.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Dogan, T. Aybek, P. S. Risteski, F. Detho, A. Rapp, G. Wimmer-Greinecker, and A. Moritz
Minimally Invasive Port Access Versus Conventional Mitral Valve Surgery: Prospective Randomized Study
Ann. Thorac. Surg., February 1, 2005; 79(2): 492 - 498.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Enc, B. Ketenci, D. Ozsoy, G. Camur, I. Kayacioglu, S. Terzi, and S. Cicek
Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump?
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1129 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. R. Nowicki, N. J. O. Birkmeyer, R. W. Weintraub, B. J. Leavitt, J. H. Sanders, L. J. Dacey, R. A. Clough, R. D. Quinn, D. C. Charlesworth, D. A. Sisto, et al.
Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England
Ann. Thorac. Surg., June 1, 2004; 77(6): 1966 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Pettersson, M. Nores, and A. M. Gillinov
Transfemoral control of ruptured aortic pseudoaneurysm at aortic root reoperation
Ann. Thorac. Surg., January 1, 2004; 77(1): 311 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Wimmer-Greinecker, S. Dogan, T. Aybek, M. F. Khan, S. Mierdl, C. Byhahn, and A. Moritz
Totally endoscopic atrial septal repair in adults with computer-enhanced telemanipulation
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 465 - 468.
[Abstract] [Full Text] [PDF]


Home page
Crit Care NurseHome page
D. L.-M. Wiegand
Advances in Cardiac Surgery: Valve Repair
Crit. Care Nurse, April 1, 2003; 23(2): 72 - 90.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. J. McCreath, M. Swaminathan, J. V. Booth, B. Phillips-Bute, S. T.H. Chew, D. D. Glower, and M. Stafford-Smith
Mitral valve surgery and acute renal injury: port access versus median sternotomy
Ann. Thorac. Surg., March 1, 2003; 75(3): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. W. Donias, H. L. Karamanoukian, G. D'Ancona, and E. L. Hoover
Minimally Invasive Mitral Valve Surgery: From Port Access to Fully Robotic-Assisted Surgery
Angiology, January 1, 2003; 54(1): 93 - 101.
[Abstract] [PDF]


Home page
Card Surg AdultHome page
E. A. Hessel II and L. H. Edmunds Jr.
Extracorporeal Circulation: Perfusion Systems
Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
S. Dogan, K. Graubitz, T. Aybek, M. F. Khan, P. Kessler, A. Moritz, and G. Wimmer-Greinecker
How safe is the port access technique in minimally invasive coronary artery bypass grafting?
Ann. Thorac. Surg., November 1, 2002; 74(5): 1537 - 1543.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. P. Kypson and D. D. Glower
Minimally invasive tricuspid operation using port access
Ann. Thorac. Surg., July 1, 2002; 74(1): 43 - 45.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. M.A. Melfi, G. F. Menconi, A. M. Mariani, and C. A. Angeletti
Early experience with robotic technology for thoracoscopic surgery
Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 864 - 868.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Torracca, G. Ismeno, and O. Alfieri
Totally endoscopic computer-enhanced atrial septal defect closure in six patients
Ann. Thorac. Surg., October 1, 2001; 72(4): 1354 - 1357.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. Grossi, A. LaPietra, G. H. Ribakove, J. Delianides, R. Esposito, A. T. Culliford, C. C. Derivaux, R. M. Applebaum, I. Kronzon, B. M. Steinberg, et al.
Minimally invasive versus sternotomy approaches for mitral reconstruction: Comparison of intermediate-term results
J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 708 - 713.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. Grossi, A. C. Galloway, G. H. Ribakove, P. K. Zakow, C. C. Derivaux, F. G. Baumann, D. Schwesinger, and S. B. Colvin
Impact of minimally invasive valvular heart surgery: a case-control study
Ann. Thorac. Surg., March 1, 2001; 71(3): 807 - 810.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. G. Byrne, L. Aklog, D. H. Adams, L. H. Cohn, and S. F. Aranki
Reoperative CABG using left thoracotomy: a tailored strategy
Ann. Thorac. Surg., January 1, 2001; 71(1): 196 - 200.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. B. Colvin, E. A. Grossi, and A. C. Galloway
Regarding ethics of rapid surgical technological advancement
Ann. Thorac. Surg., November 1, 2000; 70(5): 1758 - 1758.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. LaPietra, E. A. Grossi, C. C. Derivaux, R. M. Applebaum, C. D. Hanjis, G. H. Ribakove, A. C. Galloway, P. M. Buttenheim, B. M. Steinberg, A. T. Culliford, et al.
Robotic-assisted instruments enhance minimally invasive mitral valve surgery
Ann. Thorac. Surg., September 1, 2000; 70(3): 835 - 838.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. D. Glower, L. C. Siegel, K. J. Frischmeyer, A. C. Galloway, G. H. Ribakove, E. A. Grossi, N. B. Robinson, W. H. Ryan, and S. B. Colvin
Predictors of outcome in a multicenter port-access valve registry
Ann. Thorac. Surg., September 1, 2000; 70(3): 1054 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. A. Chaney, M. Morales, and M. Bakhos
Severe Incisional Pain and Long Thoracic Nerve Injury After Port-Access Minimally Invasive Mitral Valve Surgery
Anesth. Analg., August 1, 2000; 91(2): 288 - 290.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. M. El-Fiky, T. El-Sayegh, A. S. El-Beishry, M. Abdul Aziz, H. Aboul Enein, S. Waheid, and I. A. Sallam
Limited right anterolateral thoracotomy for mitral valve surgery
Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 710 - 713.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
F. G. Duhaylongsod
Minimally Invasive Cardiac Surgery Defined
Arch Surg, March 1, 2000; 135(3): 296 - 301.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Cartier, S. Brann, F. Dagenais, R. Martineau, and A. Couturier
SYSTEMATIC OFF-PUMP CORONARY ARTERY REVASCULARIZATION IN MULTIVESSEL DISEASE: EXPERIENCE OF THREE HUNDRED CASES
J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 221 - 229.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. D. Glower, J. Komtebedde, F. M. Clements, N. P. Debruijn, M. Stafford-Smith, and M. F. Newman
Direct aortic cannulation for port-access mitral or coronary artery bypass grafting
Ann. Thorac. Surg., November 1, 1999; 68(5): 1878 - 1880.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. Grossi, M. A. Groh, E. A. Lefrak, G. H. Ribakove, R. A. Albus, A. C. Galloway, and S. B. Colvin
Results of a prospective multicenter study on port-access coronary bypass grafting
Ann. Thorac. Surg., October 1, 1999; 68(4): 1475 - 1477.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
B. Glenville
Minimally invasive cardiac surgery
BMJ, July 17, 1999; 319(7203): 135 - 136.
[Full Text]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
L. C. Siegel
Port-Access Cardiac Surgery: Anesthetic Techniques, Equipment, Applications, Experience, and Outcomes
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 74 - 84.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
T. M. McLoitghlin JR
Complications of Minimally Invasive Cardiac Surgical Procedures
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 136 - 142.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Aubrey C. Galloway
Richard J. Shemin
Donald D. Glower
Thomas A. Burdon
Bruce A. Reitz
Stephen B. Colvin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galloway, A. C.
Right arrow Articles by Colvin, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galloway, A. C.
Right arrow Articles by Colvin, S. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS